ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

AXSM Axsome Therapeutics Inc

74.92
0.12 (0.16%)
Última actualización: 09:45:06
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Axsome Therapeutics Inc AXSM NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.12 0.16% 74.92 09:45:06
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
75.00 73.31 77.98 74.80
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
06/5/202407:09IHMARKETNEWSIndex Futures Point to Strong Monday Opening, Building on..
06/5/202406:05EDGAR2Form 8-K - Current report
06/5/202406:00GLOBEAxsome Therapeutics Reports First Quarter 2024 Financial..
01/5/202406:00GLOBEAxsome Therapeutics Recognizes May as Mental Health..
15/4/202406:00GLOBEAxsome Therapeutics Highlights Innovative Neuroscience..
10/4/202406:00GLOBEAxsome Therapeutics to Report First Quarter 2024 Financial..
01/4/202406:00GLOBEAxsome Therapeutics Initiates ENGAGE Phase 3 Trial of..
25/3/202406:00GLOBEAxsome Therapeutics Announces Results of CRESCENDO..
25/3/202405:30GLOBEAxsome Therapeutics Announces AXS-12 Achieves Primary..
19/3/202406:00GLOBEAxsome Therapeutics Initiates PARADIGM Phase 3 Trial of..
05/3/202406:00GLOBEAxsome Therapeutics to Present at the Leerink Partners..
29/2/202417:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202417:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202416:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202406:00GLOBEAxsome Therapeutics to Present at the TD Cowen 44th Annual..
23/2/202407:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/2/202406:05EDGAR2Form 8-K - Current report
20/2/202406:00GLOBEAxsome Therapeutics Reports Fourth Quarter and Full Year..
20/2/202404:37IHMARKETNEWSMarket Cautiousness Ahead of Retail Giants’ Earnings; Oil..
14/2/202414:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/1/202406:00GLOBEAxsome Therapeutics to Report Fourth Quarter and Full Year..
08/1/202406:10EDGAR2Form 8-K - Current report
04/1/202406:11EDGAR2Form 8-K - Current report
04/1/202406:00GLOBEAxsome Therapeutics Provides Preliminary Fourth Quarter and..
11/12/202306:00GLOBEAxsome Therapeutics Presents New Data and Post-Hoc Analyses..
07/12/202315:05EDGAR2Form 8-K - Current report
07/12/202306:00GLOBEAxsome Therapeutics Hosts Solriamfetol Virtual Investor..
22/11/202306:00GLOBEAxsome Therapeutics to Host Solriamfetol Virtual Investor..
21/11/202306:00GLOBEAxsome Therapeutics to Present at the Piper Sandler 35th..
06/11/202315:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202306:05EDGAR2Form 8-K - Current report
06/11/202306:00GLOBEAxsome Therapeutics Reports Third Quarter 2023 Financial..
06/11/202305:54IHMARKETNEWSMonday’s Wall Street Highlights: Berkshire Hathaway, Tesla,..
02/11/202306:00GLOBEAxsome Therapeutics and the Global Alzheimer’s Disease..
31/10/202306:00GLOBEAxsome Therapeutics to Present at Upcoming Investor..
24/10/202306:00GLOBEAxsome Therapeutics Presents Results of the ACCORD trial of..
11/10/202316:03EDGAR2Form 8-K - Current report
11/10/202306:00GLOBEAxsome Therapeutics Appoints Dr. Sue Mahony to its Board of..
10/10/202306:00GLOBEAxsome Therapeutics to Report Third Quarter 2023 Financial..
02/10/202306:00GLOBEAxsome Therapeutics Joins the National Alliance on Mental..
21/9/202306:00GLOBEAxsome Therapeutics Joins the Global Narcolepsy Community in..
15/9/202317:32EDGAR2Form 144 - Report of proposed sale of securities
15/9/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202306:03GLOBEAxsome Therapeutics Highlights Commitment to Innovating..
05/9/202306:00GLOBEAxsome Therapeutics to Present at Three Upcoming Investor..
15/8/202306:45EDGAR2Form 8-K - Current report
07/8/202316:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202315:02EDGAR2Form 8-K - Current report
07/8/202306:00GLOBEAxsome Therapeutics Reports Second Quarter 2023 Financial..
04/8/202315:49EDGAR2Form 8-K - Current report

Su Consulta Reciente

Delayed Upgrade Clock